Breast cancer and hormone-replacement therapy: the Million Women Study

Comment

Stephen Put Yin Yong. Lancet. 2003.

. 2003 Oct 18;362(9392):1331; author reply 1332.

doi: 10.1016/S0140-6736(03)14597-7.

No abstract available

Comment on

Breast cancer and hormone-replacement therapy: up to general practice to pick up the pieces.
Lagro-Janssen T, Rosser WW, van Weel C. Lagro-Janssen T, et al. Lancet. 2003 Aug 9;362(9382):414-5. doi: 10.1016/S0140-6736(03)14095-0. Lancet. 2003. PMID: 12927422 No abstract available.

Breast cancer and hormone-replacement therapy: the Million Women Study.
Bliss JM, Gray R. Bliss JM, et al. Lancet. 2003 Oct 18;362(9392):1328-9; author reply 1330-1. doi: 10.1016/S0140-6736(03)14591-6. Lancet. 2003. PMID: 14575984 No abstract available.
Estrogen therapy and breast cancer.
Gambrell RD Jr. Gambrell RD Jr. Int J Fertil. 1990 Jul-Aug;35(4):202-4. Int J Fertil. 1990. PMID: 1977710 No abstract available.
The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment.
Chlebowski RT, Anderson GL. Chlebowski RT, et al. J Natl Cancer Inst. 2011 Feb 16;103(4):284-5. doi: 10.1093/jnci/djq561. Epub 2011 Jan 28. J Natl Cancer Inst. 2011. PMID: 21278357 No abstract available.
[Does menopausal hormonal replacement therapy increase the risk of breast cancer?].
Punnonen R. Punnonen R. Duodecim. 1996;112(12):1110-5. Duodecim. 1996. PMID: 10593013 Review. Finnish. No abstract available.
Use of HRT and the subsequent risk of cancer.
Beral V, Banks E, Reeves G, Appleby P. Beral V, et al. J Epidemiol Biostat. 1999;4(3):191-210; discussion 210-5. J Epidemiol Biostat. 1999. PMID: 10695959 Review.